help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on April 1, 2004, doi:10.1165/rcmb.2003-0307OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-0307OCv1
31/2/162    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, S.-M.
Right arrow Articles by Martin, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, S.-M.
Right arrow Articles by Martin, T. R.
American Journal of Respiratory Cell and Molecular Biology. Vol. 31, pp. 162-170, 2004
© 2004 American Thoracic Society
DOI: 10.1165/rcmb.2003-0307OC

Differential Regulation of Membrane CD14 Expression and Endotoxin-Tolerance in Alveolar Macrophages

Shu-Min Lin, Charles W. Frevert, Osamu Kajikawa, Mark M. Wurfel, Kimberly Ballman, Stephen Mongovin, Venus A. Wong, Amy Selk and Thomas R. Martin

Pulmonary Research Laboratories at the VA Puget Sound Medical Center, and the Division of Pulmonary/Critical Care Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; and Department of Thoracic Medicine II, Chang Gung Memorial Hospital, Taipei, Taiwan

Address correspondence to: Charles W. Frevert, D.V.M., Sc.D., Pulmonary Research Group, VA Puget Sound Medical Center, 1660 S. Columbian Way, 151L, Seattle, WA 98108. E-mail: cfrevert{at}u.washington.edu

CD14 is important in the clearance of bacterial pathogens from lungs. However, the mechanisms that regulate the expression of membrane CD14 (mCD14) on alveolar macrophages (AM) have not been studied in detail. This study examines the regulation of mCD14 on AM exposed to Escherichia coli in vivo and in vitro, and explores the consequences of changes in mCD14 expression. The expression of mCD14 was decreased on AM exposed to E. coli in vivo and AM incubated with lipopolysaccharide (LPS) or E. coli in vitro. Polymyxin B abolished LPS effects, but only partially blocked the effects of E. coli. Blockade of extracellular signal–regulated kinase pathways attenuated LPS and E. coli–induced decrease in mCD14 expression. Inhibition of proteases abrogated the LPS-induced decrease in mCD14 expression on AM and the release of sCD14 into the supernatants, but did not affect the response to E. coli. The production of tumor necrosis factor-{alpha} in response to a second challenge with Staphylococcus aureus or zymosan was decreased in AM after incubation with E. coli but not LPS. These studies show that distinct mechanisms regulate the expression of mCD14 and the induction of endotoxin tolerance in AM, and suggest that AM function is impaired at sites of bacterial infection.

Abbreviations: alveolar macrophages, AM • differential interference contrast, DIC • dimethyl sulfoxide, DMSO • extracellular signal–regulated kinase, ERK • interleukin, IL • lipopolysaccharide, LPS • membrane CD14, mCD14 • mitogen-activated protein, MAP • phosphate-buffered saline, PBS • phosphatidylinositol-specific phospholipase, PI-PLC • soluble CD14, sCD14 • sodium dodecyl sulfate–polyacrylamide gel electrophoresis, SDS-PAGE • tumor necrosis factor-{alpha}, TNF-{alpha}




This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
J. T. Mao, D. P. Tashkin, I-H. Tsu, and K. J. Serio
Differential Modulation of Leukotriene B4 Synthesis and Degradation in Human Bronchoalveolar Lavage Cells by Lipopolysaccharide and Tobacco Smoke
Cancer Prevention Research, September 1, 2008; 1(4): 266 - 274.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. S. Berenson, C. T. Wrona, L. J. Grove, J. Maloney, M. A. Garlipp, P. K. Wallace, C. C. Stewart, and S. Sethi
Impaired Alveolar Macrophage Response to Haemophilus Antigens in Chronic Obstructive Lung Disease
Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 31 - 40.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
T. R. Martin and C. W. Frevert
Innate Immunity in the Lungs
Proceedings of the ATS, December 1, 2005; 2(5): 403 - 411.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. A. Daniel, T. H. Elsasser, A. Martinez, B. Steele, B. K. Whitlock, and J. L. Sartin
Interleukin-1{beta} and tumor necrosis factor-{alpha} mediation of endotoxin action on growth hormone
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E650 - E657.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. P. Senft, T. R. Korfhagen, J. A. Whitsett, S. D. Shapiro, and A. M. LeVine
Surfactant Protein-D Regulates Soluble CD14 through Matrix Metalloproteinase-12
J. Immunol., April 15, 2005; 174(8): 4953 - 4959.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2004 American Thoracic Society.